Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.36 - $56.4 $1,753 - $274,668
4,870 Added 0.48%
1,015,004 $487,000
Q2 2022

Aug 12, 2022

BUY
$1.91 - $5.11 $412,244 - $1.1 Million
215,835 Added 27.17%
1,010,134 $2.87 Million
Q1 2022

May 13, 2022

SELL
$5.02 - $10.47 $13,297 - $27,735
-2,649 Reduced 0.33%
794,299 $3.99 Million
Q4 2021

Feb 14, 2022

BUY
$8.95 - $16.88 $5.55 Million - $10.5 Million
620,019 Added 350.43%
796,948 $7.95 Million
Q3 2021

Nov 12, 2021

BUY
$12.2 - $16.75 $26,034 - $35,744
2,134 Added 1.22%
176,929 $2.3 Million
Q2 2021

Aug 13, 2021

BUY
$12.03 - $17.51 $2.1 Million - $3.06 Million
174,795 New
174,795 $2.46 Million

About Finch Therapeutics Group, Inc.


  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $572M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.